Cargando…

Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is a common type of cancer originating from the pancreatic glands and is characterized by a rapidly progressive course and a dismal prognosis. Currently, chemotherapy is the cornerstone of treatment that has modest efficacy. Targeted treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakrabarti, Sakti, Kamgar, Mandana, Mahipal, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179239/ https://www.ncbi.nlm.nih.gov/pubmed/35681565 http://dx.doi.org/10.3390/cancers14112588

Ejemplares similares

Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm
por: Chakrabarti, Sakti, et al.
Publicado: (2020)

A Patient With Locally Advanced Mismatch-Repair-Deficient Pancreatic Ductal Adenocarcinoma Successfully Treated With Neoadjuvant Immunotherapy
por: Cox, Ronald E, et al.
Publicado: (2021)

Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions
por: Chakrabarti, Sakti, et al.
Publicado: (2020)

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review
por: Chakrabarti, Sakti, et al.
Publicado: (2020)

Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
por: Jain, Aditi, et al.
Publicado: (2021)

Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)
por: Chakrabarti, Sakti, et al.
Publicado: (2022)

A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data
por: Tella, Sri Harsha, et al.
Publicado: (2023)

Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)—basis and current status
por: Ramaswamy, Anant, et al.
Publicado: (2022)

Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives
por: Lellouche, Lisa, et al.
Publicado: (2021)

Current epidemiology of pancreatic cancer: Challenges and opportunities
por: Luo, Wenhao, et al.
Publicado: (2020)

Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities
por: Myo Min, Kay K., et al.
Publicado: (2023)

Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
por: Greene, Michelle K., et al.
Publicado: (2021)

Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies
por: Bazeed, Alaa Y., et al.
Publicado: (2022)

Review of Current Systemic Therapy and Novel Systemic Therapy for Pancreatic Ductal Adenocarcinoma
por: Sarfraz, Humaira, et al.
Publicado: (2023)

Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib
por: Yu, James, et al.
Publicado: (2021)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
por: Yu, Yiqi, et al.
Publicado: (2021)

Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges
por: Poh, Ashleigh R., et al.
Publicado: (2021)

Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines
por: Mohamed, Amr, et al.
Publicado: (2022)

Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities
por: Deng, Siyuan, et al.
Publicado: (2020)

Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma
por: Huffman, Brandon M., et al.
Publicado: (2022)

Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
por: Rémond, M.S., et al.
Publicado: (2022)

The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experience
por: Mohamed, Amr, et al.
Publicado: (2023)

Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
por: Adamska, Aleksandra, et al.
Publicado: (2017)

Current and Future Therapies for Pancreatic Ductal Adenocarcinoma
por: Sally, Áine, et al.
Publicado: (2022)

Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma
por: Nakaoka, Kazunori, et al.
Publicado: (2023)

Current Challenges and Opportunities of Photodynamic Therapy against Cancer
por: Huis in ‘t Veld, Ruben V., et al.
Publicado: (2023)

Infant Cereals: Current Status, Challenges, and Future Opportunities for Whole Grains
por: Klerks, Michelle, et al.
Publicado: (2019)

Current Status, Opportunities, and Challenges of Exosomes in Oral Cancer Diagnosis and Treatment
por: Liu, Hongyu, et al.
Publicado: (2022)

Maternal vaccination—current status, challenges, and opportunities
por: Kurasawa, Kentaro
Publicado: (2022)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
por: Rebelo, Rita, et al.
Publicado: (2021)

The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview
por: Quiñonero, Francisco, et al.
Publicado: (2019)

Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature
por: Hull, Ashleigh, et al.
Publicado: (2020)

CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
por: Kankeu Fonkoua, Lionel A., et al.
Publicado: (2022)

PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities
por: Liu, Xuelian, et al.
Publicado: (2023)

Gene Therapy for Pancreatic Diseases: Current Status
por: Kamimura, Kenya, et al.
Publicado: (2018)

CT Imaging Assessment of Pancreatic Adenocarcinoma Resectability after Neoadjuvant Therapy: Current Status and Perspective on the Use of Radiomics
por: Khasawneh, Hala, et al.
Publicado: (2023)

Mycobacterium bovis induced human tuberculosis in India: Current status, challenges & opportunities
por: Singh, Ajay Vir, et al.
Publicado: (2022)

Metallic Biomaterials: Current Challenges and Opportunities
por: Prasad, Karthika, et al.
Publicado: (2017)

Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities
por: Manrai, Manish, et al.
Publicado: (2021)

Molecular Therapies for Inherited Retinal Diseases—Current Standing, Opportunities and Challenges
por: Vázquez-Domínguez, Irene, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9d2vnj6im59j4pnl4gstc8n10t